Skip to main content
Top
Published in: Digestive Diseases and Sciences 10/2021

01-10-2021 | Eosinophilic Esophagitis | EDITORIAL

When Not to Use a Generic: Measuring HRQoL in Chronic Digestive Disease Necessitates the Use of Disease-Specific Questionnaires

Author: Tiffany H. Taft

Published in: Digestive Diseases and Sciences | Issue 10/2021

Login to get access

Excerpt

Health-Related Quality of Life (HRQoL) is a complex, subjective construct that encompasses patient perceptions of the social, emotional, occupational, functional, and financial effects of a chronic medical condition [1]. Guidance from the US Food and Drug Administration (FDA) strongly encourages measuring HRQoL as a secondary outcome in pharmaceutical clinical trials, further emphasizing the importance of questionnaire selection. In this issue of Digestive Diseases and Sciences, Chang and colleagues [2] report on how the MOS Short-Form 36 (SF-36), a widely used cross-condition measure of HRQoL, relates to symptom severity in a cohort of patients with eosinophilic esophagitis (EoE). The authors conclude the SF-36 may have limitations as a tool to evaluate HRQoL in these patients. …
Literature
1.
go back to reference Wilson IB, Cleary PD. Linking clinical variables with health-related quality of life: a conceptual model of patient outcomes. JAMA 1995;273:59–65CrossRef Wilson IB, Cleary PD. Linking clinical variables with health-related quality of life: a conceptual model of patient outcomes. JAMA 1995;273:59–65CrossRef
3.
go back to reference Patrick DL, Deyo RA. Generic and disease-specific measures in assessing health status and quality of life. Med Care 1989;27:S217–S232CrossRef Patrick DL, Deyo RA. Generic and disease-specific measures in assessing health status and quality of life. Med Care 1989;27:S217–S232CrossRef
4.
go back to reference Lucendo AJ, Arias-Gonzalez L, Molina-Infante J et al. Systematic review: health-related quality of life in children and adults with eosinophilic oesophagitis-instruments for measurement and determinant factors. Aliment Pharmacol Ther 2017;46:401–409CrossRef Lucendo AJ, Arias-Gonzalez L, Molina-Infante J et al. Systematic review: health-related quality of life in children and adults with eosinophilic oesophagitis-instruments for measurement and determinant factors. Aliment Pharmacol Ther 2017;46:401–409CrossRef
5.
go back to reference Brazier JE, Harper R, Jones NM et al. Validating the SF-36 health survey questionnaire: new outcome measure for primary care. BMJ 1992;305:160–164CrossRef Brazier JE, Harper R, Jones NM et al. Validating the SF-36 health survey questionnaire: new outcome measure for primary care. BMJ 1992;305:160–164CrossRef
6.
go back to reference Taft TH, Kern E, Kwiatek MA et al. The adult eosinophilic oesophagitis quality of life questionnaire: a new measure of health-related quality of life. Aliment Pharmacol Ther 2011;34:790–798CrossRef Taft TH, Kern E, Kwiatek MA et al. The adult eosinophilic oesophagitis quality of life questionnaire: a new measure of health-related quality of life. Aliment Pharmacol Ther 2011;34:790–798CrossRef
7.
go back to reference Straumann A, Lucendo AJ, Miehlke S et al. Budesonide orodispersible tablets maintain remission in a randomized, placebo-controlled trial of patients with eosinophilic esophagitis. Gastroenterology 2020;159:1672–1685CrossRef Straumann A, Lucendo AJ, Miehlke S et al. Budesonide orodispersible tablets maintain remission in a randomized, placebo-controlled trial of patients with eosinophilic esophagitis. Gastroenterology 2020;159:1672–1685CrossRef
8.
go back to reference Hirano I, Dellon ES, Hamilton JD et al. Efficacy of dupilumab in a phase 2 randomized trial of adults with active eosinophilic esophagitis. Gastroenterology 2020;158:111-122 e10CrossRef Hirano I, Dellon ES, Hamilton JD et al. Efficacy of dupilumab in a phase 2 randomized trial of adults with active eosinophilic esophagitis. Gastroenterology 2020;158:111-122 e10CrossRef
9.
go back to reference De La Loge C, Trudeau E, Marquis P et al. Responsiveness and interpretation of a quality of life questionnaire specific to upper gastrointestinal disorders. Clin Gastroenterol Hepatol 2004;2:778–786CrossRef De La Loge C, Trudeau E, Marquis P et al. Responsiveness and interpretation of a quality of life questionnaire specific to upper gastrointestinal disorders. Clin Gastroenterol Hepatol 2004;2:778–786CrossRef
10.
go back to reference Eypasch E, Williams JI, Wood-Dauphinee S et al. Gastrointestinal Quality of Life Index: development, validation and application of a new instrument. Br J Surg 1995;82:216–222CrossRef Eypasch E, Williams JI, Wood-Dauphinee S et al. Gastrointestinal Quality of Life Index: development, validation and application of a new instrument. Br J Surg 1995;82:216–222CrossRef
Metadata
Title
When Not to Use a Generic: Measuring HRQoL in Chronic Digestive Disease Necessitates the Use of Disease-Specific Questionnaires
Author
Tiffany H. Taft
Publication date
01-10-2021
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 10/2021
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-020-06780-8

Other articles of this Issue 10/2021

Digestive Diseases and Sciences 10/2021 Go to the issue